Company / SG&A Expense
CANNABIS SUISSE CORP. SG&A Expense History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$228.7K
FY2024
5-year range
$135.6K / $228.7K
FY2020-FY2024
Trend
+30.9%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $135,612 to $228,654 over the past 2 years.
Based on SEC 10-K filings.
$228,654 in FY2024 with a 5-year CAGR of +5.6%.
Increased from $135,612 to $228,654 over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +19.0%
- 5-Year CAGR
- +5.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +5.6%, indicating consistent growth.
- In FY2024, sg&a expense increased 30.9% year-over-year.
- Lowest sg&a expense in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -4.63 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $228.7K | +30.9% |
| FY2023 | $174.7K | +28.8% |
| FY2022 | $135.6K | +0.0% |
| FY2021 | $135.6K | -22.2% |
| FY2019 | $174.4K | +10644.5% |
| FY2018 | $1.6K | +0.0% |
| FY2017 | $1.6K | - |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026